DETECTION AND IDENTIFICATION OF D6 AND DUFFY ANTIGEN/RECEPTOR FOR CHEMOKINES (DARC) BY ANTIBODY BASED ASSAYS

Authors

  • Tan Wee Yee Institute For Research In Molecular Medicine (INFORMM), Universiti Sains Malaysia, USM, Penang, 11800, Malaysia
  • Darah Ibrahim Industrial Biotechnology Research Laboratory (IBRL), School of Biological Sciences, Universiti Sains Malaysia, USM, Penang, 11800, Malaysia
  • Khoo Boon Yin Institute For Research In Molecular Medicine (INFORMM), Universiti Sains Malaysia, USM, Penang, 11800, Malaysia
  • Chew Ai Lan Institute For Research In Molecular Medicine (INFORMM), Universiti Sains Malaysia, USM, Penang, 11800, Malaysia

DOI:

https://doi.org/10.11113/jt.v78.9857

Keywords:

D6, DARC, Western Blot, Pichia-GS115

Abstract

D6 and DARC are decoy chemokine binding receptors. They had been studied extensively in recent years for their role in breast cancer studies. The purpose of this study was to improve some critical steps in Western Blot in order to detect and identify recombinant D6 and DARC which has been expressed intracellularly by Pichia-GS115. Total proteins of Pichia-GS115 were obtained by breaking the yeast cells using acid-washed glass beads. Then, the lysates were treated with treatment buffer before electrophoresed on SDS-polyacrylamide gel. Western Blot was carried out after SDS PAGE to detect and identify the presence of recombinant D6 and DARC. Several parameters of Western Blot were studied and improved to enhance the specificity of results obtained. It was found that blocking of nitrocellulose membrane with 3% (w/v) skimmed milk at room temperature for 1 hour, incubation of primary antibody at the dilution of 1: 300 at room temperature for 16 hours and incubation of secondary antibody at the dilution of 1: 1000 at room temperature for 1 hour were able to enhance the sensitivity and specificity of Western Blot results. With the aid of prestained protein ladder as a marker, recombinant D6 and also DARC were shown as clear and precise bands at the range of molecular weight of 50-60 kDa on developed films using ECL substrate. The film exposure time was found to be 5 minutes for D6 and 10 minutes for DARC. As a result, the studies showed that improved Western Blot condition detected and identified the presence of recombinant D6 and DARC in the cell pellets of Pichia-GS115

References

Adams, E. F., B. Rafferty, and M. C. White. 1991. Interleukin-6 is Secreted by Breast Fibroblasts and Stimulates 17 Beta-oestradiol Oxidoreductase Activity of MCF-7 Cells: Possible Paracrine Regulation of Breast 17 Beta-oestradiol Levels. International Journal of Cancer. 49 (1):118 - 121.

Adnane, J., P. Gaudray, and C. Dionne. 1991. BEK and FLG, Two Receptors to Members of the FGF Family, Are Amplified in Subsets of Human Breast Cancers. Oncogene. 6:659 - 663.

Cabioglu, N., A. A. Sahin, P. Morandi, F. Meric-Bernstam, R. Islam, H. Y. Lin, C. D. Bucana, A. M. Gonzalez-Angulo, G. N. Hortobagyi, and M. Cristofanilli. 2009. Chemokine Receptors in Advanced Breast Cancer: Differential Expression in Metastatic Disease Sites with Diagnostic and Therapeutic Implications. Annals of Oncology. 20:1013-1019.

Chew, A. L., W. Y. Tan, and B. Y. Khoo. 2013. Potential Combinatorial Effects of Recombinant Atypical Chemokine Receptors in Breast Cancer Cell Invasion: A Research Perspective (Review). Biomedical Reports. 1: 185-192.

Tan, W. Y., B. Y. Khoo, and A. L. Chew. 2013. The Construction of Recombinant D6 Clone for In Vitro Breast Cancer Study. International Journal of Bioscience, Biochemistry and Bioinformatics. 3: 509-512.

Wang, J., Z. L. Ou, Y. F. Hou, J. M. Luo, Z. Z. Shen, J. Ding, and Z. M. Shao. 2006. Enhanced Expression of Duffy Antigen Receptor for Chemokines by Breast Cancer Cells Attenuates Growth and Metastasis Potential. Oncogene. 25: 7201-7211.

Wu, F. Y., Z. L. Ou, L. Y. Feng, J. M. Luo, L. P. Wang, Z. Z. Shen, and Z. M. Shao. 2008. Chemokine Decoy Receptor D6 Plays a Negative Role in Human Breast Cancer. Molecular Cancer Research. 6: 1276-1288.

Zeng, X. H., Z. L. Ou, K. D. Yu, L. Y. Feng, W. J. Yin, J. Li, Z. Z. Shen, and Z. M. Shao. 2011. Coexpression of Atypical Chemokine Binders (ACBs) in Breast Cancer Predicts Better Outcomes. Breast Cancer Research and Treatment. 125: 715-727.

Galzi, J. L., M. Hachet-Haas, D. Bonnet, F. Daubeuf, S. Lecat, M. Hibert, J. Haiech, and N. Frossard. 2010. Neutralizing Endogenous Chemokines with Small Molecules: Principles and Potential Therapeutic Applications. Pharmacology & Therapeutics. 126: 39-55.

Mantovani, A., B. Savino, M. Locati, L. Zammataro, P. Allavena, and R. Bonecchi. 2010. The Chemokine System in Cancer Biology and Therapy. Cytokine & Growth Factor Reviews. 21: 27-39.

Laemmli, U.K. 1970. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature. 227: 680-685.

Dankwa, S., C. Lim, A. K. Bei, R. H. Y. Jiang, J. R. Abshire, S. D. Patel, J. M. Goldberg, Y. Moreno, M. Kono, J. C. Niles, and M. T. Duraisingh. 2016. Ancient Human Sialic Acid Variant Restricts an Emerging Zoonotic Malaria Parasite. Nature Communications. 7: 11187.

Huang, W., W. Qin, L. Lv, H. Deng, H. Zhang, J. Zhang, and L. Zhang. 2014. Duffy Antigen/ Receptor for Chemokines Correlates with Inflammatory Reactions in Rats with Inflammatory Venous Hypertension: Implications for the Pathogenesis of Primary Chronic Venous Disease. Original Communication. 43: 47-54.

Nguyen, K. A., M. Arensman, A. R. Lay, N. P. Rao, T. Donahue, X. Li, S. W. French, and D. W. Dawson. 2013. HOXB7 Promotes Invasion and Predicts Survival in Pancreatic Adenocarcinoma. Cancer. 119: 529-539.

Cho, G. J., E. S. Lee, H. M. Jin, J. H. Lee, Y. S. Kim, M. Oh, H. Seol, S. Hong, and H. Kim. 2015. Placental Expression of D6 Decoy Receptor in Preeclampsia. Obstetrics and Gynecology Science. 58 (5): 333-339.

Downloads

Published

2016-11-27

How to Cite

DETECTION AND IDENTIFICATION OF D6 AND DUFFY ANTIGEN/RECEPTOR FOR CHEMOKINES (DARC) BY ANTIBODY BASED ASSAYS. (2016). Jurnal Teknologi, 78(11-3). https://doi.org/10.11113/jt.v78.9857